- Home
- LEGN vs MSGS Comparison
LEGN vs MSGS Comparison
Compare LEGN & MSGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- MSGS
- Stock Information
- Founded
- LEGN 2014
- MSGS 1879
- Country
- LEGN United States
- MSGS United States
- Employees
- LEGN N/A
- MSGS N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- MSGS Services-Misc. Amusement & Recreation
- Sector
- LEGN Health Care
- MSGS Consumer Discretionary
- Exchange
- LEGN Nasdaq
- MSGS Nasdaq
- Market Cap
- LEGN 5.4B
- MSGS 4.5B
- IPO Year
- LEGN 2020
- MSGS N/A
- Fundamental
- Price
- LEGN $28.95
- MSGS $189.70
- Analyst Decision
- LEGN Strong Buy
- MSGS Buy
- Analyst Count
- LEGN 12
- MSGS 5
- Target Price
- LEGN $77.09
- MSGS $252.60
- AVG Volume (30 Days)
- LEGN 1.9M
- MSGS 127.8K
- Earning Date
- LEGN 05-13-2025
- MSGS 05-02-2025
- Dividend Yield
- LEGN N/A
- MSGS N/A
- EPS Growth
- LEGN N/A
- MSGS N/A
- EPS
- LEGN N/A
- MSGS 0.20
- Revenue
- LEGN $728,303,000.00
- MSGS $1,062,514,000.00
- Revenue This Year
- LEGN $64.21
- MSGS N/A
- Revenue Next Year
- LEGN $53.69
- MSGS $7.34
- P/E Ratio
- LEGN N/A
- MSGS $946.40
- Revenue Growth
- LEGN 112.46
- MSGS 14.64
- 52 Week Low
- LEGN $27.34
- MSGS $173.26
- 52 Week High
- LEGN $60.87
- MSGS $237.99
- Technical
- Relative Strength Index (RSI)
- LEGN 41.56
- MSGS 44.79
- Support Level
- LEGN $28.13
- MSGS $186.72
- Resistance Level
- LEGN $29.31
- MSGS $192.34
- Average True Range (ATR)
- LEGN 1.63
- MSGS 3.17
- MACD
- LEGN 0.03
- MSGS -0.64
- Stochastic Oscillator
- LEGN 27.01
- MSGS 24.26
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About MSGS Madison Square Garden Sports Corp. (New)
Madison Square Garden Sports Corp owns and operates a portfolio of assets featuring some of the recognized sports teams, including the Knicks of the NBA and the Rangers of the NHL. It generates revenue from several sources: ticket sales and a portion of suite rental fees at The Garden and others. It has one operating and reportable segment and one reporting unit for goodwill impairment testing purposes.